Fibrinogen is a clotting protein and one of the most used inflammation markers. In 154,211 adults, each 1 g/L higher level was linked to about 2.4 times the rate of heart disease. But it added little to standard risk checks, and gene studies do not show it causes heart disease.
This article is part of our series on [how to test for inflammation](/articles/how-to-test-for-inflammation).
The numbers
Fibrinogen is reported in grams per liter (g/L) or milligrams per deciliter (mg/dL). A gram is 1,000 milligrams, and a liter is 10 deciliters. So 1 g/L is the same as 100 mg/dL. Your lab prints its own normal range next to your result, so compare against that line first.
| Number | What it means | Source |
|---|---|---|
| 154,211 people, 31 studies | The biggest pooled look at fibrinogen and heart risk, in adults with no heart disease at the start | |
| 2.42 | Hazard ratio for coronary heart disease per 1 g/L higher usual fibrinogen, adjusted for age and sex | |
| About 1.8 | The same hazard ratio after also adjusting for other heart risk factors | |
| 0.0027 | How much fibrinogen improved a standard heart risk score (C-index), in 246,669 people | |
| 34% to 50% | How much of the difference in fibrinogen between people is inherited | |
| 3.13 | Hazard ratio for death per doubling of fibrinogen in people with stable COPD |
A hazard ratio compares how often something happens in two groups. A ratio of 2.42 means about 2.4 times the rate.
Now the part no one prints on a lab report. This is our arithmetic, not the study's. In a model of 100,000 adults, 13,199 people sat in the "intermediate risk" group, and testing them for fibrinogen or CRP could help prevent about 30 heart attacks or strokes over 10 years. That is 13,199 divided by 30: about 440 people tested to help one person. And the fibrinogen gain of 0.0027 is roughly half of the 0.0050 gain that the study got from adding HDL cholesterol.
So fibrinogen does tell you something. Your cholesterol test tells you more.
Is fibrinogen an inflammation marker?
Yes. Fibrinogen, CRP (C-reactive protein) and IL-6 (interleukin 6, a signal immune cells send) are the most established inflammation markers in clinical practice for heart disease, diabetes and heart failure. Fibrinogen is an acute-phase reactant: a blood protein that changes with inflammation.
So fibrinogen does tell you something. Your cholesterol test tells you more.From a 2012 study in N Engl J Med
Its first job is clotting. But clotting proteins like fibrinogen also tip the balance between fighting infection and too much inflammation. Most of that detail comes from 43 animal studies, in diseases like multiple sclerosis, rheumatoid arthritis and colitis. The genes that set your fibrinogen level point the same way. A study of over 100,000 people found 23 gene regions tied to fibrinogen, and the pathways included inflammation.
What does high fibrinogen mean for your heart?
It means a higher risk, on average, and a weaker clue than you might think.
The 2005 pooled analysis followed people for 1.38 million person-years. In every age group studied, from 40 to 59 up to 70 and older, higher fibrinogen came with more heart disease, stroke and other deaths. There was no threshold. The risk climbed in a smooth line.
Then the researchers adjusted for blood pressure, cholesterol and other known risk factors. The hazard ratio dropped from 2.42 to about 1.8. A good part of the link travels with things doctors already measure.
The gene study is the twist. If fibrinogen itself harmed arteries, people born with genes for higher fibrinogen should have more heart disease. Across tens of thousands of people with coronary artery disease, compared with people without it, the combined gene effect did not show that. The authors concluded their results do not support a causal link with heart disease, stroke or blood clots in veins. The 2005 authors had flagged this years earlier.
Still, a 2025 review argues fibrinogen may do more than ride along, because in people with diabetes more of it carries sugar, and it forms clots that resist breaking down. That is a mechanism. It is not proof.
What moves the number
Your genes. Inherited factors explain 34% to 50% of the differences between people.
Exercise. A meta-analysis of 25 randomized studies in people with coronary artery disease found fibrinogen was lower after exercise programs than in control groups. The authors called for larger, better trials.
Body size. In 776 adults aged 54 to 74, a higher body mass index and a bigger waist were both linked to higher fibrinogen.
Medicines. Across 22 head-to-head trials with 2,762 people, fibrates (a cholesterol medicine) lowered fibrinogen by 40.7 mg/dL more than statins did. By our unit math, that is about 0.4 g/L.
Smoking, maybe less than you'd guess. In 1,652 smokers, how much a person smoked was not linked to fibrinogen. Among 344 people who quit for a year, fibrinogen did not change in a way tied to quitting. Their white blood cell counts did fall.
When a number should worry you
When it is high and your heart risk is in the middle. The 2012 study found the payoff from testing in people at intermediate risk, who were not clearly low or high. For them, a high result is a reason to look hard at blood pressure and cholesterol.
When you have COPD. In people with stable COPD, higher fibrinogen was linked to more deaths and more flare-ups.
When it is low, or you bleed or clot easily. Inherited problems with fibrinogen can lead to anything from bleeding to blood clots. A low or odd result, or unusual bruising, needs a doctor's look, not a lifestyle fix.
What to do with your number
Tick what you'll try this week. Your picks stay on this device.
your fibrinogen is low, you bruise or bleed easily, a relative has a bleeding or clotting disorder, you take a blood thinner, you have COPD, liver disease or heart disease, or you are pregnant.
One tap. Results appear once 50 readers have voted, and the count is always real.
Reader stories
What happened for you?
Studies tell us what works on average. You know what happened in your own body. Share it here, and the next person who reads this page gets something no study can give them.
A reader who shared their story here sent you this article. When you're ready, add yours.
Ask the Research Desk
Heard something about inflammation you want checked? The best questions become articles, credited by first name only if you say yes.
How this article was made
Researched and written from 11 peer-reviewed papers. Our automated check matched every claim against the exact words of its source, confirmed every paper exists in PubMed, and found none retracted. Checked November 5, 2026. Not individually reviewed by a doctor. Photos are illustrative; the people in them are not patients or readers.
Grades run Strong, Moderate, Emerging, Early and Not supported, and the grade decides the words we may use. How we grade evidence · Medical disclaimer
Sources
- Meta-analysisPlasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.Danesh J, Lewington S, Thompson SG et al. JAMA, 2005.PubMedFull paper
- StudyC-reactive protein, fibrinogen, and cardiovascular disease prediction.Kaptoge S, Di Angelantonio E, Pennells L et al. N Engl J Med, 2012.PubMedFull paper
- Meta-analysisMultiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated Loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease.Sabater-Lleal M, Huang J, Chasman D et al. Circulation, 2013.PubMedFull paper
- Meta-analysisHead-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis.Sahebkar A, Serban MC, Mikhailidis DP et al. Pharmacol Res, 2016.PubMedFull paper
- ReviewRevisiting C-reactive Protein, Interleukin 6 and Fibrinogen: Markers or Mediators of Cardiovascular Disease?Papa A, Balzan S, Lubrano V et al. Theor Biol Forum, 2025.PubMedFull paper
- Systematic reviewThe Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A Systematic Review.Göbel K, Eichler S, Wiendl H et al. Front Immunol, 2018.PubMedFull paper
- CohortLongitudinal Impact of Smoking and Smoking Cessation on Inflammatory Markers of Cardiovascular Disease Risk.King CC, Piper ME, Gepner AD et al. Arterioscler Thromb Vasc Biol, 2017.PubMedFull paper
- Meta-analysisExercise and inflammation in coronary artery disease: A systematic review and meta-analysis of randomised trials.Thompson G, Davison GW, Crawford J et al. J Sports Sci, 2020.PubMedFull paper
- Cross-sectionalBody Mass Index and Waist Circumference as Determinants of Hemostatic Factors in Participants of a Population-Based Study.Iglesias Morcillo M, Freuer D, Peters A et al. Medicina (Kaunas), 2023.PubMedFull paper
- Meta-analysisBiomarkers and clinical outcomes in COPD: a systematic review and meta-analysis.Fermont JM, Masconi KL, Jensen MT et al. Thorax, 2019.PubMedFull paper
- Systematic reviewCongenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review.Li Y, Ding B, Wang X et al. Thromb Res, 2022.PubMedFull paper
